Shares in Acambis plc plunged 38 percent on the London Stock Exchange Tuesday on news that the U.S. Department of Health and Human Services is no longer considering its bid for a government contract to supply a stockpile of next-generation smallpox vaccines, based on the modified vaccinia ankara (MVA) vector. (BioWorld International) Read More
